熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
愛(ài)爾蘭ICON PLC
ICON plc是一家為制藥、生物技術(shù)和醫(yī)療器械行業(yè)提供外包開(kāi)發(fā)服務(wù)的全球提供商。公司專門從事支持臨床開(kāi)發(fā)的戰(zhàn)略制定、管理和分析,涵蓋范圍從化合物篩選到I至IV期臨床試驗(yàn)。ICON目前聘用約8300名員工,在39個(gè)國(guó)家的77個(gè)地點(diǎn)開(kāi)展業(yè)務(wù)。
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies
In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis.
We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution.
These services are delivered by the following ICON Divisions.
ICON Central Laboratories - Global central laboratory services dedicated exclusively to clinical trials
--------------------------------------------------------------------------------
ICON Clinical Research - Planning , management, execution and analysis of Phase IIb – IV clinical trials
--------------------------------------------------------------------------------
ICON Contracting Solutions - Contract and permanent staffing solutions for pharmaceutical and biotech companies
--------------------------------------------------------------------------------
ICON Development Solutions - Product development planning , early phase clinical development, and expertise in regulatory affairs, pk/ biopharmaceutics and bioanalytics
--------------------------------------------------------------------------------
ICON Medical Imaging - Medical imaging based development solutions, including independent imaging review and database delivery to regulatory authorities